Internet Addiction and Sleep Disorders (ADDICSOM)

This is an open label randomized controlled trial, comparing two modes of treatment for internet addiction (gaming or gambling online) with sleep disorders associated.

Study Overview

Detailed Description

We will check sleep disorders among patients presenting internet dependence. Diagnosis will be followed by a specific treatment during three months. This treatment is expected to reduce prevalence of internet dependence and associated addictive disorders (alchohol, nicotine) . rate of sleep disorders is also expected to decrease under treatment.

This is an open label randomized controlled trial, comparing two modes of treatment for internet addiction (gaming or gambling online) with sleep disorders associated.

Patients will be randomised in two arms : controls (CBT treatment of Internet dependence) and intervention (CBT treatment of addiction plus CBT treatment of sleep disorders).

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75018
        • Bichat-Claude.Bernard

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Internet addiction (Young scale ≥5)
  • Online compulsive gambling ( DSM IV scale for pathological gambling and SOGS) and/or addiction to online gaming (problem video game playing ≥ 5)
  • sleep latency >45 min/night and more than 3 nights a week
  • subjective total sleep time <6h30/night more than 3 nights a week
  • Adult patient

Exclusion Criteria:

  • cognitive impairments, memory disorders, non french-speaking patients
  • already known and on treatment sleep pathologies
  • somatic conditions non compatible with clinical evaluation
  • cybersex dependance
  • Treatment with dopaminergic agents
  • patients under jurisdictional assistance
  • patients non covered by the french health system
  • non consenting patients
  • History of Healthcare for internet dependence
  • Patients already treated for internet dependance
  • pregnant or lactating women
  • Patients already participating in other studies on internet dependance and sleeping disorders
  • suicide attempt before inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control
CBT treatment of internet dependence each two weeks during 3 months
CBT treatment of internet dependence
Experimental: intervention
CBT treatment of internet dependence plus CBT treatment of sleep disorders during 3 months
CBT treatment of internet dependence
CBT treatment of sleep disorders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of hours each week spent gaming or online gambling
Time Frame: 6 months
The evaluation period will be 7 days of follow-up visit at 6 months. Each patient will complete a connection agenda that will provide the therapist during follow-up visits.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of hours spent on line gaming or online gambling
Time Frame: 3 months
3 months
insomnia
Time Frame: 3 and 6months
measure with Insomnia Severity Index (ISI)
3 and 6months
daytime sleepiness
Time Frame: 3 and 6 months
daytime sleepiness with specific scales ( Epworth and KAROLINSKA)
3 and 6 months
total sleep time
Time Frame: 3 and 6 months
total sleep time (actimetry, sleep agenda) Actimetry results will be centrally reviewed by experts blinded to realization date
3 and 6 months
number of awakenings during night
Time Frame: 3 and 6 months
number of awakenings during night (actimetry) Actimetry results will be centrally reviewed by experts blinded to realization date
3 and 6 months
treatment with hypnotics
Time Frame: 3 and 6 months
Number of tablets taken each week
3 and 6 months
Depression
Time Frame: 3 and 6 months
score of depression at the MINI questionnaire
3 and 6 months
Anxiety
Time Frame: 3and 6 months
Anxiety scores at the MINI questionnaire
3and 6 months
Alcohol dependence
Time Frame: 3 and 6 months
Alcohol dependence assess with severity AUDIT scale
3 and 6 months
Nicotine Dependence
Time Frame: 3 and 6 months
assess with Fagerstrom scale
3 and 6 months
Other psychoactive agents
Time Frame: 3 and 6 months
assess with RDAPS questionnaire
3 and 6 months
Compliance
Time Frame: 3 and 6 months
Compliance will be studied with the participation of patients to CBT groups at 3 and 6 months.
3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lejoyeux Lejoyeux, Professor, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Anticipated)

February 1, 2019

Study Completion (Anticipated)

February 1, 2019

Study Registration Dates

First Submitted

March 11, 2015

First Submitted That Met QC Criteria

March 11, 2015

First Posted (Estimate)

March 17, 2015

Study Record Updates

Last Update Posted (Actual)

May 16, 2017

Last Update Submitted That Met QC Criteria

May 14, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

At the end of the study, patient could be informed of result of the study if they wish.

No individual result will be communicate.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Internet Addiction

Clinical Trials on CBT treatment of internet dependence

3
Subscribe